Showing results (171-180 of 1,148) with videos related to
Sort By:
Pageof 115
Clinical Nuclear Medicine|May 23, 2012
Patellar metastasis from lung adenocarcinoma revealed by FDG PET/CTIon Codreanu, Hongming Zhuang, Abass Alavi, et al.Clinical Nuclear Medicine|August 16, 2005
Detection of bone marrow metastases by FDG-PET and missed by bone scintigraphy in widespread melanomaAysel Aydin, Jian Q Yu, Hongming Zhuang, et al.European Journal of Nuclear Medicine and Molecular Imaging|November 3, 2009
FDG PET/CT in carcinoma of unknown primaryThomas C Kwee, Sandip Basu, Gang Cheng, et al.European Journal of Nuclear Medicine and Molecular Imaging|January 31, 2013
When should we recommend use of dual time-point and delayed time-point imaging techniques in FDG PET?Gang Cheng, Drew A Torigian, Hongming Zhuang, et al.PET Clinics|May 10, 2016
PET, CT, and MR Imaging for Assessment of Thoracic Malignancy: Structure Meets FunctionSharyn Katz, Thomas Ferrara, Abass Alavi, et al.PET Clinics|November 14, 2018
Clinical Applications of Positron Emission Tomography in the Evaluation of Spine and Joint DisordersAbdullah Al-Zaghal, Cyrus Ayubcha, Esha Kothekar, et al.Current Osteoporosis Reports|September 14, 2024
PET/CT for the Opportunistic Screening of Osteoporosis and Fractures in Cancer PatientsPeter Sang Uk Park, Thomas J Werner, Abass AlaviPET Clinics|May 10, 2016
Evaluating the Role of Fluorodeoxyglucose PET Imaging in the Management of Patients with SarcoidosisJian Q Yu, Hongming Zhuang, Ayse Mavi, et al.PET Clinics|June 18, 2022
Positron Emission Tomography-Based Assessment of Cognitive Impairment and Dementias, Critical Role of Fluorodeoxyglucose in such SettingsAndrew B Newberg, Roger Coble, Mohsen Khosravi, et al.Journal of Alzheimer'S Disease : JAD|May 23, 2022
Alzheimer's Disease at a Crossroad: Time to Part from Amyloid to More Promising Aspects-Atherosclerosis for a StartPoul F Høilund-Carlsen, Mona-Elisabeth Revheim, Abass AlaviPageof 115